Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/5/25 16:11 | 9/5/25 | DYN | Health | Drug | Pharmaceutical Preparations | Cox John | MA | DO | CEO,P | 4 | S | -193 | 14.36 | 0 | -13 | 272 | D | |||||||||||||||
12/5/25 16:09 | 12/5/25 | DYN | Health | Drug | Pharmaceutical Preparations | Kerr Douglas | MA | O | Chief Me | 4 | S.m | -111 | 13.88 | 0 | -8 | 94 | D | |||||||||||||||
12/5/25 16:08 | 12/5/25 | DYN | Health | Drug | Pharmaceutical Preparations | Friedl-Naderer Johanna | MA | O | Chief Co | 4 | S.m | -20 | 13.91 | 0 | -1 | 96 | D | |||||||||||||||
3/13/25 16:08 | 3/11/25 | DYN | Health | Drug | Pharmaceutical Preparations | Scalzo Richard William | MA | O | SVP,Head | 5 | S | -179 | 20.01 | 0 | -9 | 127 | D | |||||||||||||||
3/13/25 16:08 | 3/11/25 | DYN | Health | Drug | Pharmaceutical Preparations | Beskrovnaya Oxana | MA | O | Chief Sc | 5 | S | -220 | 19.92 | 0 | -11 | 202 | D | |||||||||||||||
12/10/24 16:05 | 12/6/24 | DYN | Health | Drug | Pharmaceutical Preparations | Kersten Dirk | MA | D | 7 | S.m | -14,842 | 30.55 | 0 | -486 | 5,924 | I | ||||||||||||||||
11/18/24 19:42 | 11/18/24 | DYN | Health | Drug | Pharmaceutical Preparations | Incerti Carlo | MA | D | 1 | S.d | -474 | 28.73 | 0 | -17 | -100 | 0 | D | |||||||||||||||
11/18/24 17:31 | 11/14/24 | DYN | Health | Drug | Pharmaceutical Preparations | Rhodes Jason P | MA | D | 1 | S | -26 | 33.10 | 0 | -1 | 0 | 847 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |